Common and Rare Hematological Manifestations and Adverse Drug Events during Treatment of Active TB: A State of Art

Common and Rare Hematological Manifestations and Adverse Drug Events during Treatment of Active TB: A State of Art

Background: Tuberculosis (TB) can seriously affect the hematopoietic system, with involvement of both myeloid and lymphoid cell lines as well as plasma components. These hematological changes act as a marker for the diagnosis, prognosis and response to therapy. Methods: We searched PubMed, Scopus, G...

Full description

Bibliographic Details
Main Authors: Maria Letizia Minardi, Ilenia Fato, Francesco Di Gennaro, Silvia Mosti, Annelisa Mastrobattista, Carlotta Cerva, Raffaella Libertone, Annalisa Saracino, Delia Goletti, Enrico Girardi, Massimo Andreoni, Fabrizio Palmieri, Gina Gualano
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Microorganisms
Subjects:
tuberculosis
adverse events
hematopoietic system
anemia
rare hematologic disorders
Online Access:https://www.mdpi.com/2076-2607/9/7/1477

Internet

https://www.mdpi.com/2076-2607/9/7/1477

Similar Items